When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Ozempic is under clinical development by Novo Nordisk and currently in Phase III for Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD).

Stay updated on the latest developments in the GLP-1 drug class, including a new generic entering the market, weight loss results, FDA decisions & cost issues.

Following rapid (and pricey) expansion efforts from Novo and Lilly, plus recent shortage updates at the FDA, “positive ...

As weight-loss drugs have exploded in popularity this past year, part of the craze has been members of the public wondering which celebrities are on Ozempic.

In recent developments, health officials in Europe have launched an investigation into the popular weight loss drug Ozempic, ...

Ozempic has become a popular wonder drug among many Hollywood celebrities, who turned to the diabetes medication to lose ...

Novo Nordisk's GLP-1 receptor agonist semaglutide ... which is already seeing sales rocket on the back of its use as Ozempic for diabetes, Wegovy for obesity, and label extensions for both brands ...

From weight-loss drugs to nonopioid pain killers to AI, here are some important -- and positive -- trends in health care.

Novo Nordisk is planning to open an artificial intelligence (AI) research facility in London, UK, as part of a drive to place the technology at the heart of its drug discovery operations.

Officials said it could take up to 10 days to prepare the dead for transport, with the uncertainty adding to the shock and grief of relatives packed into an airport hall. By John Yoon The ...